Sun Pharmaceutical Industries Limited (SUNPHARMA.NS)

1.506,55 -13,60 (-0,89%) Alla chiusura: 03:30PM IST

Sun Pharmaceutical Industries Limited

Sun House
Plot No. 201 B/1 Western Express Highway Goregaon (East)
Mumbai 400063
India
91 22 4324 4324
https://www.sunpharma.com

Settore/i: Healthcare
Settore: Drug Manufacturers - Specialty & Generic
Impiegati a tempo pieno: 41.000

Figure dirigenziali chiave

Nome	Titolo	Retribuzione	Esercitate	Anno di nascita
Mr. Dilip Shantilal Shanghvi	MD & Executive Director	54,53M	N/D	1955
Mr. Kalyanasundaram Subramanian	Director of Corporate Development	65,3M	N/D	1954
Mr. C. S. Muralidharan	Chief Financial Officer	38,89M	N/D	1963
Mr. Davinder Singh	Executive Vice-President of Global Operations	N/D	N/D	N/D
Mr. Dheeraj Prasad Sinha BE	EVP & Chief Information Officer	N/D	N/D	1971
Mr. Nimish Desai	Head of Investor Relations	N/D	N/D	N/D
Mr. Anoop Deshpande	Company Secretary & Compliance Officer	N/D	N/D	N/D
Mr. Suresh Kumar Rai	Chief Human Resources Officer	N/D	N/D	N/D
Mr. Kirti Wardhaman Ganorkar	Chief Executive Officer of India Business	N/D	N/D	1967
Mr. Aalok Dilip Shanghvi	Executive VP, Head of Emerging Markets, Global Generics R&D, Business Devp., and Whole Time Director	N/D	N/D	1984

Gli importi risalgono al giorno 31 dicembre 2023 e i valori di compensazione riguardano l'anno fiscale che si chiude a tale data. La retribuzione include salari, bonus ecc. "Esercitate" è il valore delle opzioni esercitate durante l'anno fiscale. Valuta in INR.

Descrizione

Sun Pharmaceutical Industries Limited, a generic pharmaceutical company, develops, manufactures, and markets branded and generic formulations and active pharmaceutical ingredients (APIs) in India and internationally. The company offers formulations in various therapeutic areas, including central nervous system, dermatology, cardiology, oncology, neuropsychiatry, gastroenterology, anti-infectives, diabetology, pain/analgesics, vitamins/minerals/nutrients, respiratory, gynaecology, urology, ophthalmology, orthopaedic, nephrology, dental, and other areas. It provides APIs for anti-cancers, peptides, steroids, hormones, and immunosuppressant drugs. In addition, the company offers generic medications, such as tablets, capsules, injectables, inhalers, ointments, creams, and liquids; speciality medications, and anti retro viral medications, as well as over-the-counter products. The company was founded in 1983 and is based in Mumbai, India.

Governance aziendale

L'ISS Governance QualityScore di Sun Pharmaceutical Industries Limited al 1 aprile 2024 è 2. I criteri di valutazione fondamentali sono revisione: 4; Consiglio di Amministrazione: 2; diritti degli azionisti: 1; retribuzione: 6.

Punteggi di corporate governance forniti da Institutional Shareholder Services (ISS). I punteggi indicano il rango decile relativo all’indice o alla regione. Un punteggio di decile pari a 1 indica un governance risk più basso, mentre un punteggio di 10 indica un governance risk più alto.